Protein Requirements in Male and Female Endurance Athletes

University of Toronto

Status: Completed

Conditions: Healthy; Increased Metabolic Requirement

Treatments: Dietary Supplement: Amino Acid Intake

Study type: Interventional

Funder types: Other

Identifiers

NCT04855474

IAAO-ETFM

Details and patient eligibility

About

Protein is an essential macronutrient for post-exercise recovery through its ability to provide the amino acid building blocks that support increased rates of muscle and whole body protein synthesis.

Despite the growing understanding of the importance of post-exercise protein in endurance athlete populations, the impact of sex and female menstrual cycle phase on protein metabolism is not fully understood. To date, no studies have examined protein requirements in female endurance trained athletes.

The aim of the proposed study is to utilize the well-established IAAO method to determine protein requirements in endurance trained female and male athletes in a "real-world" and at-home setting.

Enrollment: 16 patients

Sex: All

Ages: 18 to 35 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy endurance trained runners. Total weekly running distance of greater than 50km/week and perform endurance exercise for more than 5 hours/week.
• Age 18-35 years old
• Eumenorrheic over last 3 months (one cycle no longer than 42 days and no shorter than 20 days).
• Not using hormonal contraceptives (the pill, implants and injections, hormonal intrauterine devices (IUDs), vaginal ring, skin patch).
• Do not have polycystic ovarian syndrome (PCOS) or other conditions effecting ovarian hormone regularity.
• Not pregnant within the past year.
• Must meet the classification of 'superior' aerobic power for their respective age category based on the ACSM criteria; (women age 20-29 years VO2max >50ml/kg/min and women age 30-35 years VO2max >46ml/kg/min) (men age 20-29 years VO2max >56ml/kg/min and men age 30-35 years VO2max >54ml/kg/min).

Exclusion criteria

• Inability to meet health and physical activity guidelines according to the CSEP 'Get Active' Questionnaire (Appendix G).
• Inability to adhere to study protocol requirements relating to diet and exercise (i.e. alcohol and caffeine consumption, training/exercise prior to beginning a study testing day).
• Regular use of tobacco and/or other recreational drugs/banned substances (i.e. growth hormone, testosterone, marijuana).
• Self-reported intentional or unintentional weight loss (past 6 months) or plan to lose weight (>5-10kg).
• Amenorrhea (self-reported) in the past 3 months.
• Fewer than 6 menstrual cycles per year.
• Answering yes to any questions asked within the COVID-19 screening questionnaire until 14 days of being symptom free and/or having a negative COVID-19 test

Trial design

Primary purpose: Basic Science

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: None (Open label)

---

16 participants in 3 patient groups

Low Protein

Experimental group

Description:

0.2 g/kg/day of protein provided as crystalline amino acid made after egg protein.

Treatment:

Dietary Supplement: Amino Acid Intake

Moderate Protein

Experimental group

Description:

1.2g/kg/day of protein provided as crystalline amino acid made after egg protein.

Treatment:

Dietary Supplement: Amino Acid Intake

High Protein

Experimental group

Description:

2.0 g/kg/day of protein provided as crystalline amino acid made after egg protein.

Treatment:

Dietary Supplement: Amino Acid Intake